White House un­veils ‘bold goals’ for US bio­man­u­fac­tur­ing ef­forts

The US gov­ern­ment is set­ting more goals around bio­man­u­fac­tur­ing ef­forts, with a vi­sion for stronger sup­ply chains and greater do­mes­tic pro­duc­tion.

A 64-page re­port re­leased by The White House on Thurs­day lays out “bold goals,” in­clud­ing an aim to pro­duce at least a quar­ter of all ac­tive phar­ma­ceu­ti­cal in­gre­di­ents in the US for small-mol­e­cule drugs with­in five years. While some of the re­port is cen­tered around cli­mate change and agri­cul­tur­al ini­tia­tives, it al­so presents goals for health and sup­ply chain re­silience.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN